# PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk

Study · id `cardio:ct-nct01314313` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01314313](<https://clinicaltrials.gov/study/NCT01314313>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01314313

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2032 participants.

## Technical summary

Registry record NCT01314313. Randomized; no masking; primary purpose treatment. Start 2011-03 (actual); primary completion 2016-01 (actual). Results posted on 2018-08-14.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2032 participants (enrolled count; ClinicalTrials.gov record NCT01314313, source copy `cardio:ctgov-nct01314313-2024-03-07`, retrieved 2026-10-26)
- Started: 2011-03 (actual) (ClinicalTrials.gov record NCT01314313, source copy `cardio:ctgov-nct01314313-2024-03-07`, retrieved 2026-10-26)
- Primary completion: 2016-01 (actual) (ClinicalTrials.gov record NCT01314313, source copy `cardio:ctgov-nct01314313-2024-03-07`, retrieved 2026-10-26)
- Completion: 2024-01-17 (actual) (ClinicalTrials.gov record NCT01314313, source copy `cardio:ctgov-nct01314313-2024-03-07`, retrieved 2026-10-26)
- Results first posted: 2018-08-14 (ClinicalTrials.gov record NCT01314313, source copy `cardio:ctgov-nct01314313-2024-03-07`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT01314313, source copy `cardio:ctgov-nct01314313-2024-03-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01314313-2024-03-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk
- Acronym: PII A
- Condition: Symptomatic Severe Aortic Stenosis
- Intervention (Device): TAVR Implantation with SAPIEN XT
- Intervention (Device): SAVR Implantation
- Lead sponsor: Edwards Lifesciences
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Edwards Lifesciences (`cardio:edwards-lifesciences`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients (`cardio:pubmed-27040324`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis (`cardio:pubmed-27400898`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial (`cardio:pubmed-28658491`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk (`cardio:pubmed-30586747`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement (`cardio:pubmed-31995682`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Incidence and Clinical Significance of Worsening Tricuspid Regurgitation Following Surgical or Transcatheter Aortic Valve Replacement: Analysis From the PARTNER IIA Trial (`cardio:pubmed-34266311`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: 10-Year Randomized Outcomes of Transcatheter or Surgical Aortic Valve Replacement in Intermediate-Risk Aortic Stenosis (`cardio:pubmed-42300821`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 1e06a932c513ded99110dce3e4bb958de306656774cb95eb30173bdaae9f28ed
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
